CHRNA4 and Alzheimer disease: In patients with Alzheimer's disease, the level of PSCA protein in the frontal cortex increases, this in turn decreases the function of nAChRs in these patients, so PSCA-nAChR interactions may be effective in cognitive function, especially in AD pathology [78].